NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer

British Journal of Cancer

Volumn 74, Issue 9, 1996, Pages 1413-1418

  Lindmark, G ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell proliferative index; DNA ploidy; nm23 H1; p53 colorectal cancer

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL PROLIFERATION; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PLOIDY; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR BIOPSY; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 0029828922     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.557     Document Type: Article

References (49)

1. AYHAN A, YASUI W, YOKOZAKI H, KITADAI Y AND TAHARA E. (1993). Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas. Virchows Archiv. B Cell Pathol., 63, 213 218.
2. BACKER JM, MENDOLA CE, KOVESDI I, FAIRHURST JL, O'HARA B, EDDY JRRL, SHOWS TB, MATHEW S, MURTY VVVS AND CHAGANTI RSK. (1993). Chromosomal localization and nucleoside diphosphate kinase activity in human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene, 8, 497 - 502.
3. BAFICO A, VARESCO L, DE BENEDETTI L, CALLGO MA, GISMONDI V, SCIALLERO S, ASTE H, FERRARA GB AND BEVILACQUA G. (1993). Genomic PCR-SSCP analysis of the metastasis associated with NM23-H1 (NME1) gene: a study on colorectal cancer. Anticancer Res., 13, 2149 - 2154.
4. BEVILACQUA G, SOBEL ME, LIOTTA LA AND STEEG PS. (1989). Assocation of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49, 5185 - 5190.
5. BREWSTER SF, BROWNE S AND BROWN KW. (1994). Somatic allelic loss at the DCC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J. Urology, 151, 1073 - 1077.
6. CALIGO MA, CIPOLLINI G, FIORE L, CALVO S, BASOLO F, COLLECCHI P, CIARDELLO F, PEPE S, PETRINI M AND BEVILACQUA G. (1995). NM23 gene expresssion correlates with cell growth rate and S-phase. Int. J. Cancer, 60, 837 - 842.
7. CAMPO E, MIQUEL R, JARES P, BOSCH F, JUAN M, LEONE A, VIVES J, CARDESA A, YAGUE J. (1994). Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer, 73, 2913 - 2921.
8. CAWKWELL L, LEWIS FA AND QUIRKE P. (1994). Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br. J. Cancer, 70, 813 - 818.
9. COHN K, WANG F, DESOTO-LAPAIX F, SOLOMON WB, PETTERSON LG, ARNOLD MR, WEIMAR J, FELDMAN JG, LEVY AT, LEONE A AND STEEG PS. (1991). Association of nm23-H1 allelic deletions with distinct metastases in colorectal carcinoma. Lancet, 338, 722 - 724.
10. DUKES CE AND BUSSEY HJR. (1958). The spread of rectal cancer and its effect on prognosis. Br. J. Cancer, 12, 309 - 320.
11. FEARON E. (1994). Molecular genetic studies of the adenoma-carcinoma sequence. Adv. Intern. Med., 39, 123 - 147.
12. FLORENES VA, AAMDAL S, MYKLEBOST O, MAELANDSMO GM, BRULAND OS AND FODSTAID O. (1992). Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res., 52, 6088 - 6091.
13. GLIMELIUS B, ISACSSON U, JUNG AND PÅHLMAN L. (1995). Radiotherapy in addition to radical surgery in rectal cancer. Acta Oncol., 34, 565 - 570.
14. HAUT M, STEEG PS, WILLSON JKV AND MARKOWITZ SD. (1991). Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J. Natl Cancer Inst., 83, 712 - 716.
15. HEIDE I, THIEDE C, POPPE K, DE KANT E, HUHN D AND ROCHLITZ C. (1994). Expression and mutational analysis of nm23-H1 in liver metastases of colorectal cancer. Br. J. Cancer, 70, 1267 - 1271.
16. HENNESSY C, HENRY JA, MAY FEB, WESLEY BR, ANGUS B AND LENNARD TWJ. (1991). Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl Cancer Inst., 83, 281 - 285.
17. HIRAYAMA R, SAWAI S, TAKAGI Y, MISHIMA Y, KIMURA N, SHIMADA N, ESAKI Y, KURASHIMA C, UTSUYAMA M AND HIROKAWA K. (1991). Positive relationship between expression of anti-metastatic factor (nm23 gene product of nucleoside diphosphate kinase) and good prognosis in human breast cancer. J. Natl Cancer Inst., 83, 1249 - 1250.
18. HOWLETT AR, PETERSEN OW, STEEG PS AND BISSELL MJ. (1994). A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J. Natl Cancer Inst., 86, 1838 - 1844.
19. HUWER H, ENGEL M, WELTER C, DOOLEY S, KALWEIT G, FEINDT P AND GAMS E. (1994). Squamous cell carcinoma of the lung: does the nm23 gene expression correlate to the tumor stage? Thorac. Cardiovasc. Surg., 42, 298 - 301.
20. IACOPETTA B, DIGRANDI S, DIX B, HAIG C, SOONG R AND HOUSE A. (1994). Loss of heterozygosity of tumor suppressor gene loci in human colorectal carcinoma. Eur. J. Cancer, 30A, 664 - 670.
21. IIZUKA N, OKA M, NOMA T, NAKAZAWA A, HIROSE K AND SUZUKI T. (1995). NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res., 55, 652 - 657.
22. KRESSNER U, LINDMARK G, GERDIN B, PȦHLMAN L AND GLIMELIUS B. (1996). Immunohistochemical p53 staining of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res., 16, 951 - 958.
23. LACOMBE M-L, SASTRE-GARAU X, LASCU I, VONICA A, WALLET V, THIERY JP AND VERON M. (1991). Overexpression of nucleoside diphosphate kinase (nm23) in solid tumours. Eur. J. Cancer, 27, 1302 - 1307.
24. LAWLESS JF. (1982). Statistical Methods and Models for Life-time Data. Wiley: New York.
25. LEONE A, MCBRIDE OW, WESTON A, WANG MG, ANGLARD P, CROPP CS, GOEPEL JR, LIDEREAU R, CALLAHAN R, LINEHAN M, REES RC, HARRIS CC, LIOTTA LA AND STEEG PS. (1991). Somatic allelic deletions in nm23 in human cancer. Cancer Res., 51, 2490 - 2493.
26. LEONE A, SEEGER RC, HONG CM, HU YY, ARBOLEDA MJ, BRODEUO GM, STRAM D, SLAMON DJ AND STEEG PS. (1993). Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene, 8, 855 - 865.
27. LINDMARK G, PÅHLMAN J, GLIMELIUS B AND ENBLAD P. (1991). Heterogeneity in ploidy and S-phase fraction in colorectal cancer. Int. J. Colorect. Dis., 6, 115 - 120.
28. LINDMARK G, GERDIN B, PȦLHMAN L AND GLIMELIUS B. (1994). Prognostic predictors in colorectal cancer. Dis. Colon Rectum, 37, 1219 - 1227.
29. LIOTTA LA, STETLER-STEVENSON W AND STEEG PS. (1991). Metastasis suppressor genes. Important Adv. Oncol., 85 - 100.
30. LOMBARDI D, SACCHI A, D'ANGOSTINO G AND TIBURSI G. (1995). The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation. Exp. Cell Res., 217, 267 - 271.
31. MANDAI M, KONISHI I, KOSHIYAMA M, MORI T, ARAO S, TASHIRO H, OKAMURA H, NOMURA H, HIAI H AND FUKUMOTO M. (1994). Expression of metastsis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res., 54, 1825 - 1830.
32. MORSON BC AND SOBIN LH. (1976). Histological Typing of Intestinal Tumours. International Classification of Tumours No. 15. World Health Organization: Geneva.
33. MYEROFF LL AND MARKOWITZ SD. (1993). Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J. Natl Cancer Inst., 85, 147 - 152.
34. NAKAYAMA H, YASUI K, YOKOZAKI H AND TAHARA E. (1993). Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn. J. Cancer Res., 84, 184 - 190.
35. OKADA K, URANO T, GOI T, BABA H, YAMAGUCHI A, FURUKAWA K AND SHIKU H. (1994). Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. Cancer Res., 54, 3979 - 3982.
36. PETO R, PIKE MC, ARMITAGE P, BRESLOW NE, COX DR, HOWARD SV, MANTEL N, MCPHERSON K, PETO J AND SMITH PG. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and examples. Br. J. Surg., 35, 1 - 39.
37. ROYDS JA, STEPHENSON TJ, REES RC, SHORTHOUSE AJ AND SILCOCKS PB. (1993). Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J. Natl Cancer Inst., 85, 727 - 731.
38. ROYDS JA, CROSS SS, SILCOCKS PB, SCHOLEFIELD JH, REES RC AND STEPHENSON TJ. (1994). Nm23 'anti-metastatic' gene product expression in colorectal carcinoma. J. Pathol., 172, 261 - 266.
39. SASTRE-GARAU X, LACOMBE ML, JOUVE M, VÉRON M AND MAGDALÉNAT H. (1992). Nucleoside disphosphate kinase/nm23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int. J. Cancer, 50, 533 - 538.
40. STAHL JA, LEONE A, ROSENGARD AM, PORTER L, KING CR AND STEEG PS. (1991). Identification of a second human nm23 gene, nm23-H2. Cancer Res., 51, 445 - 449.
41. STEEG PS, BEVILACQUA G, KOPPER L, THORGEIRSSON UP, TALMADGE E, LIOTTA LA AND SOBEL ME. (1988). Evidence for a novel gene associated with low tumor metastatic potential. J. Natl Cancer Inst., 80, 200 - 204.
42. STEEG PS, COHN KH AND LEONE A. (1991). Tumor metastasis and nm23: current concepts. Cancer Cells, 3, 257 - 262.
43. TANNAPFEL A, KOCKERLING F, KATALINIC A AND WITTEKIND C. (1995). Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis. Colon Rectum, 38, 651 - 654.
44. TOKUNAGA Y, URANO T, FURUKAWA K, KONDO H, KANEMATSU T AND SHIKU H. (1993). Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer, 55, 66 - 71.
45. WANG L, PATEL U, GHOSH. L, CHEN H-C AND BANERJEE S (1993). Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res., 53, 717 - 720.
46. WHITELAW JL AND NORTHOVER JMA. (1994). The nm23 gene and colorectal cancer. Gut, 35, 141.
47. XERRI L, GROB JJ, BATTYANI Z, GOUVERNET J, HASSOUN J AND BONERANDI JJ. (1994). NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br. J. Cancer, 70, 1224 - 1228.
48. YAMAGUCHI A, URANO T, FUSHIDA S, FURUKAWA K, NISHIMURA G, YONEMURA Y, MIYZAKI I, NAGAKAWA G AND SHIKU H. (1993). Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br. J. Cancer, 68, 1020 - 1024.
49. ZENG ZS, HSU S, ZHANG ZF, COHEN AM, ENKER WE AND TURNBULL AA. (1994). High level of nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br. J. Cancer, 70, 1025 - 1030.